Traditionally we tend to identify and rank Emerging Experts, by defined metrics – their number of publications, their academic qualifications and awards, their involvement in trials or guid
You have a truly innovative medicine with a unique proposition in an area with a clear unmet need – in other words, a perfect recipe for advancing patient well-being and achieving brand lea
Eisai has retreated from the optimistic view of sales growth for Alzheimer's disease drug Leqembi it held earlier this year as uptake remains sluggish.
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.